Although many previous studies have elucidated that the provision of intermittent PTH contributes greatly to treating osteoporosis, these animal studies, have focused on changes of BMD or trabecular structures in vertebra body, tibia, or distal femoral metaphysis [24–26]; the effects of this anabolic agent on femoral neck were still not very clarified. The gene discussed is PTH; the disease is osteoporosis.